Acute interstitial nephritis with Prothionamide

Author:

Asnake Molla1ORCID,Henock Andualem2,Abayneh Menigistu3,Getu Shimelis4,Hailemariam Shewangizaw5,Endalkachew Biruk6,Zerihun Dessalegn7

Affiliation:

1. School of Medicine, College of Health Sciences, Mizan-Tepi University, Mizan Teferi, Ethiopia

2. School of Public Health, College of Health Sciences, Mizan-Tepi University, Mizan Teferi, Ethiopia

3. Department of Medical Laboratory Technology, College of Health Sciences, Mizan-Tepi University, Mizan Teferi, Ethiopia

4. School of Medicine, College of Health Sciences, Wolkite University, Wolkite, Ethiopia

5. Department of Midwifery, College of Health Sciences, Mizan-Tepi University, Mizan Teferi, Ethiopia

6. Department of Biomedical Science, College of Health Sciences, Mizan-Tepi University, Mizan Teferi, Ethiopia

7. USAID Eliminate TB Project, KNCV Tuberculosis Foundation, Hawassa, Ethiopia

Abstract

Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction. In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy. This drug-related side effect had not been reported. In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide. The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect. It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide.

Publisher

SAGE Publications

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Bedaquiline/protionamide;Reactions Weekly;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3